We are live on ! Find out more
GRCE

Grace Therapeutics

11 hedge funds and large institutions have $3.18M invested in Grace Therapeutics in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less capital invested

Capital invested by funds: $3.63M → $3.18M (-$450K)

35% less funds holding

Funds holding: 1711 (-6)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
11
Holders Change
-6
Holders Change %
-35.29%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
3
Closed
7
Calls
Puts
Net Calls
Net Calls Change

GRCE Hedge Fund Activity: Q1 2015 in Review

11 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q1 2015, worth a combined $3.18M — down 12% from $3.63M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of GRCE and 1 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Alpine Global Management, opening a new position worth an estimated $4.94K. The largest seller was Perceptive Advisors, cutting an estimated $102K.

  • 11 institutional investors held Grace Therapeutics (GRCE) as of Q1 2015, down from 17 in Q4 2014.
  • Funds reported $3.18M of Grace Therapeutics stock for Q1 2015, down 12% quarter-over-quarter.
  • 1 fund opened new Grace Therapeutics positions in Q1 2015 and 7 closed out, a net change of -6 holders.
  • The largest Grace Therapeutics buyer in Q1 2015 was Alpine Global Management, an estimated $4.94K added.
  • The largest Grace Therapeutics seller in Q1 2015 was Perceptive Advisors, an estimated $102K sold.

Based on aggregated 13F filings for Q1 2015.